These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 23664539)
1. Expression of group IIA phospholipase A2 is an independent predictor of favorable outcome for patients with gastric cancer. Wang X; Huang CJ; Yu GZ; Wang JJ; Wang R; Li YM; Wu Q Hum Pathol; 2013 Oct; 44(10):2020-7. PubMed ID: 23664539 [TBL] [Abstract][Full Text] [Related]
2. Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer. Xing XF; Li H; Zhong XY; Zhang LH; Wang XH; Liu YQ; Jia SQ; Shi T; Niu ZJ; Peng Y; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Chen S; Ji JF Histopathology; 2011 Aug; 59(2):198-206. PubMed ID: 21884198 [TBL] [Abstract][Full Text] [Related]
3. Decreased expression of V-set and immunoglobulin domain containing 1 (VSIG1) is associated with poor prognosis in primary gastric cancer. Chen Y; Pan K; Li S; Xia J; Wang W; Chen J; Zhao J; Lü L; Wang D; Pan Q; Wang Q; Li Y; He J; Li Q J Surg Oncol; 2012 Sep; 106(3):286-93. PubMed ID: 22095633 [TBL] [Abstract][Full Text] [Related]
4. Changes of the alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis. Xu JH; Wang YC; Geng X; Li YY; Zhang WM Pathobiology; 2009; 76(1):23-9. PubMed ID: 19188747 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene. Ganesan K; Ivanova T; Wu Y; Rajasegaran V; Wu J; Lee MH; Yu K; Rha SY; Chung HC; Ylstra B; Meijer G; Lian KO; Grabsch H; Tan P Cancer Res; 2008 Jun; 68(11):4277-86. PubMed ID: 18519687 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329 [TBL] [Abstract][Full Text] [Related]
7. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347 [TBL] [Abstract][Full Text] [Related]
9. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Leung SY; Chen X; Chu KM; Yuen ST; Mathy J; Ji J; Chan AS; Li R; Law S; Troyanskaya OG; Tu IP; Wong J; So S; Botstein D; Brown PO Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16203-8. PubMed ID: 12456890 [TBL] [Abstract][Full Text] [Related]
11. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Ebert MP; Günther T; Hoffmann J; Yu J; Miehlke S; Schulz HU; Roessner A; Korc M; Malfertheiner P Cancer Res; 2000 Apr; 60(7):1995-2001. PubMed ID: 10766190 [TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry. Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246 [TBL] [Abstract][Full Text] [Related]
14. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898 [TBL] [Abstract][Full Text] [Related]
15. Vimentin expression is associated with decreased survival in gastric cancer. Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330 [TBL] [Abstract][Full Text] [Related]
16. Differential caspase-3 expression in noncancerous, premalignant and cancer tissues of stomach and its clinical implication. Sun Y; Chen XY; Liu J; Cheng XX; Wang XW; Kong QY; Li H Cancer Detect Prev; 2006; 30(2):168-73. PubMed ID: 16697119 [TBL] [Abstract][Full Text] [Related]
17. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246 [TBL] [Abstract][Full Text] [Related]
18. Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance. Kapranos N; Kominea A; Konstantinopoulos PA; Savva S; Artelaris S; Vandoros G; Sotiropoulou-Bonikou G; Papavassiliou AG J Cancer Res Clin Oncol; 2002 Aug; 128(8):426-32. PubMed ID: 12200599 [TBL] [Abstract][Full Text] [Related]
19. Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer. Park JH; Lee BL; Yoon J; Kim J; Kim MA; Yang HK; Kim WH Hum Pathol; 2010 Dec; 41(12):1664-73. PubMed ID: 20869748 [TBL] [Abstract][Full Text] [Related]
20. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression. Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]